Introduction. Concern regarding overtreatment of prostate cancer (CaP) is leading to increased attention on active surveillance (AS). This study examined CaP survivors on AS and compared secondary treatment patterns and overall survival by race/ethnicity. Methods. The study population consisted of CaP patients self-classified as black or white followed on AS in the Center for Prostate Disease Research (CPDR) multicenter national database between 1989 and 2008. Secondary treatment included radical prostatectomy (RP), external beam radiation therapy or brachytherapy (EBRT-Br), and hormone therapy (HT). Secondary treatment patterns and overall survival were compared by race/ethnicity. Results. Among 886 eligible patients, 21% were black. Desp...
The objective of the present study is to address some important questions related to prostate cancer...
Purpose Men diagnosed with prostate cancer have multiple options available for treatment. Previous r...
BACKGROUND: The gap in prostate cancer (PCa) survival between Blacks and Whites has widened over the...
Background: Prostate cancer mortality is higher among black American men than among white American m...
Background: Population-based cancer registry data have shown that black men with prostate cancer hav...
OBJECTIVE: We examined whether there were racial differences in initial treatment for clinically loc...
BackgroundDisparities in prostate cancer-specific mortality (PCSM) between African American and non-...
ImportanceBlack men are more likely to die of prostate cancer than white men. In men with similar st...
BackgroundStudies of active surveillance (AS) for prostate cancer (PCa) have focussed predominantly ...
OBJECTIVE: We examined whether there were racial differences in initial treatment for clinically loc...
Purpose Men diagnosed with prostate cancer have multiple options available for treatment. Previous r...
The objective of the present study is to address some important questions related to prostate cancer...
Prostate cancer (CaP) is the most diagnosed non-cutaneous malignancy and the second leading cause of...
Prostate cancer (CaP) is the most diagnosed non-cutaneous malignancy and the second leading cause of...
The objective of the present study is to address some important questions related to prostate cancer...
The objective of the present study is to address some important questions related to prostate cancer...
Purpose Men diagnosed with prostate cancer have multiple options available for treatment. Previous r...
BACKGROUND: The gap in prostate cancer (PCa) survival between Blacks and Whites has widened over the...
Background: Prostate cancer mortality is higher among black American men than among white American m...
Background: Population-based cancer registry data have shown that black men with prostate cancer hav...
OBJECTIVE: We examined whether there were racial differences in initial treatment for clinically loc...
BackgroundDisparities in prostate cancer-specific mortality (PCSM) between African American and non-...
ImportanceBlack men are more likely to die of prostate cancer than white men. In men with similar st...
BackgroundStudies of active surveillance (AS) for prostate cancer (PCa) have focussed predominantly ...
OBJECTIVE: We examined whether there were racial differences in initial treatment for clinically loc...
Purpose Men diagnosed with prostate cancer have multiple options available for treatment. Previous r...
The objective of the present study is to address some important questions related to prostate cancer...
Prostate cancer (CaP) is the most diagnosed non-cutaneous malignancy and the second leading cause of...
Prostate cancer (CaP) is the most diagnosed non-cutaneous malignancy and the second leading cause of...
The objective of the present study is to address some important questions related to prostate cancer...
The objective of the present study is to address some important questions related to prostate cancer...
Purpose Men diagnosed with prostate cancer have multiple options available for treatment. Previous r...
BACKGROUND: The gap in prostate cancer (PCa) survival between Blacks and Whites has widened over the...